documents: FDA-1976-N-0520-0012
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1976-N-0520-0012 | FDA | FDA-1976-N-0520 | Certain Estrogen-Androgen Combination Drugs; Drugs for Human Use; Drug Efficacy Study Implementation; Amendment and Opportunity for Hearing | Notice | Notice of Opportunity of Hearing | 2003-04-16T04:00:00Z | 2003 | 4 | 2020-02-20T15:27:16Z | 03-9065 | 0 | 0 | 090000648053be8e |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref